Skye Bioscience
SKYE
SKYE
75 hedge funds and large institutions have $39.3M invested in Skye Bioscience in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3.36% less ownership
Funds ownership: 83.09% → 79.73% (-3.4%)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
45% less capital invested
Capital invested by funds: $71.3M → $39.3M (-$32M)
Holders
75
Holding in Top 10
3
Calls
$84K
Puts
$21K
Top Buyers
| 1 | +$309K | |
| 2 | +$147K | |
| 3 | +$146K | |
| 4 |
LPL Financial
San Diego,
California
|
+$126K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.8K |
Top Sellers
| 1 | -$708K | |
| 2 | -$372K | |
| 3 | -$250K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$224K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$140K |
